WHWK
Whitehawk Therapeutics Inc NASDAQ Listed Aug 1, 2017$4.42
+4.74%
vs $4.22
Mkt Cap $273.5M
52w Low $1.60
80.6% of range
52w High $5.10
50d MA $4.20
200d MA $3.02
P/E (TTM)
—
EV/EBITDA
—
P/B
2.0x
Debt/Equity
0.0x
ROE
-15.1%
P/FCF
-2.8x
RSI (14)
42.70
ATR (14)
$0.28
Beta
0.62
50d MA
$4.20
200d MA
$3.02
Avg Volume
443.7K
Whitehawk Therapeutics Inc operates as a clinical-stage biopharmaceutical company. The Company develops precision therapies for genetically-defined cancers.
17383 Sunset Blvd, Suite A250 · Pacific Palisades, CA 90272 · US
Data updated apr 27, 2026 9:21am
· Source: financialmodelingprep.com